ANAVEX LIFE SCIENCES CORP. Operating Leases, Future Minimum Payments Receivable, in Three Years
ANAVEX LIFE SCIENCES CORP. (AVXL) had Operating Leases, Future Minimum Payments Receivable, in Three Years of $57.59 thousand as of 2017-12-31, per its 10-Q filed 2018-02-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears · last filed 2018-02-07
- 2017-12-31: Operating Leases, Future Minimum Payments Receivable, in Three Years $57.59K.
- 2017-09-30: Operating Leases, Future Minimum Payments Receivable, in Three Years $57.59K.
- 2017-06-30: Operating Leases, Future Minimum Payments Receivable, in Three Years $56.09K.
- 2017-03-31: Operating Leases, Future Minimum Payments Receivable, in Three Years $56.09K.
| Period end | Operating Leases, Future Minimum Payments Receivable, in Three Years |
|---|---|
| 2017-12-31 | $57.59K 10-Q · filed 2018-02-07 |
| 2017-09-30 | $57.59K 10-K · filed 2017-12-11 |
| 2017-06-30 | $56.09K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $56.09K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $56.09K 10-Q · filed 2017-02-07 |
| 2016-09-30 | $56.09K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |